معرفی
Sara Valpione is a Clinical Senior Lecturer (Honorary Consultant Status) in the Division of Cancer Sciences, focusing on oncology, immunotherapy, and melanoma research. She holds an honorary medical oncology role at a clinical institution. Her work contributes to UN Sustainable Development Goals related to health and well-being.
- Academic Rank: Clinical Senior Lecturer
- Research Focus: Immunotherapy, Melanoma, Gut Microbiome, Electrochemotherapy
- Affiliations: Division of Cancer Sciences
Her research explores immune-checkpoint inhibitors, gut microbiome influences on cancer therapy, and targeted therapies for KIT-driven melanoma. Recent studies include longitudinal microbiome analyses in melanoma patients and prognostic roles of NSAIDs and metformin in immunotherapy trials.
Key Awards:
- Christie QICA Award Grand Prize (2023)
- ESMO Leaders Generation Programme (2020)
- Manchester BRC Rising Star (2022)
Collaborations span global institutions, with frequent co-publications on melanoma, immunotherapy biomarkers, and oncology treatment strategies. Her work bridges clinical practice and translational research, emphasizing personalized approaches to cancer therapy.
